These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28503962)

  • 1. Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis.
    Liu J; Wang L; Liu C; Zhang X
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):625-631. PubMed ID: 28503962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crisis in access to essential medicines in India: key issues which call for action.
    Bhargava A; Kalantri SP
    Indian J Med Ethics; 2013; 10(2):86-95. PubMed ID: 23697486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High medicine prices and poor affordability.
    Suh GH
    Curr Opin Psychiatry; 2011 Jul; 24(4):341-5. PubMed ID: 21532479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
    Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
    PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prices people pay for medicines in Zimbabwe.
    Gavaza P; Simoyi T; Makunike B; Maponga CC
    Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.
    Kwon HY; Kim H; Godman B; Reich MR
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):1007-14. PubMed ID: 26394767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future.
    Jiang M; Zhou Z; Wu L; Shen Q; Lv B; Wang X; Yang S; Fang Y
    Int J Clin Pharm; 2015 Feb; 37(1):12-7. PubMed ID: 25425142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The availability, price and affordability of antidiabetic drugs in Hubei province, China.
    Gong S; Cai H; Ding Y; Li W; Juan X; Peng J; Jin S
    Health Policy Plan; 2018 Oct; 33(8):937-947. PubMed ID: 30215707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt.
    Mohamed O; Kreling DH
    Value Health Reg Issues; 2016 Sep; 10():14-18. PubMed ID: 27881272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance.
    Zhao M; Wu J
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):311-320. PubMed ID: 27762144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.